Research graph
References from Targeting MicroRNAs in doxorubicin-induced cardiotoxicity: A systematic review of transfection studies. Local targets link to admitted publications; unresolved targets remain external evidence.
Intercalation of antitumor drug doxorubicin and its analogue by DNA duplex: structural features and biological implications
10.1016/j.ijbiomac.2014.02.028 · 2014 · External reference
Metformin ameliorates doxorubicin-induced cardiotoxicity targeting HMGB1/TLR4/NLRP3 signaling pathway in mice
10.1016/j.lfs.2023.121390 · 2023 · External reference
A comprehensive review on collagen type I development of biomaterials for tissue engineering: from biosynthesis to bioscaffold
10.3390/biomedicines10092307 · 2022 · External reference
The role of miRNAs in chemotherapy-induced cardiotoxicity
10.3390/biomedicines13102331 · 2025 · External reference
Pathophysiology of doxorubicin-mediated cardiotoxicity
10.3390/toxics13040277 · 2025 · External reference
Cancer therapy-related cardiotoxicity: a comprehensive retrospective analysis at Najran cancer center, Saudi Arabia
2023 · External reference
Cardiac fibroblasts: friend or foe?
10.1152/ajpheart.00023.2006 · 2006 · External reference
Anthracycline cardiotoxicity in adult cancer patients: JACC: cardiooncology State-of-the-Art review
10.1016/j.jaccao.2024.07.016 · 2024 · External reference
Oxidative stress and cellular response to doxorubicin: a common factor in the complex milieu of anthracycline cardiotoxicity
10.1155/2017/1521020 · 2017 · External reference
Cardioprotective effect of paeonol on chronic heart failure induced by doxorubicin via regulating the miR-21-5p/S-Phase kinase-associated protein 2 axis
2022 · External reference
Doxorubicin-induced loss of DNA topoisomerase II and DNMT1- dependent suppression of MiR-125b induces chemoresistance in ALK-positive cells
10.18632/oncotarget.24465 · 2018 · External reference
Protocol for a retrospective, controlled cohort study of the impact of a change in nature journals' editorial policy for life sciences research on the completeness of reporting study design and execution
10.1007/s11192-016-1964-8 · 2016 · External reference
Bnip3 mediates doxorubicin-induced cardiac myocyte necrosis and mortality through changes in mitochondrial signaling
10.1073/pnas.1414665111 · 2014 · External reference
miRNA expression profiles in isolated ventricular cardiomyocytes: insights into doxorubicin-induced cardiotoxicity
10.3390/ijms25105272 · 2024 · External reference
Protective effect of miR-204 on doxorubicin-induced cardiomyocyte injury via HMGB1
10.1155/2020/8819771 · 2020 · External reference
MicroRNA-194-5p attenuates doxorubicin-induced cardiomyocyte apoptosis and endoplasmic reticulum stress by targeting P21-Activated kinase 2
10.3389/fcvm.2022.815916 · 2022 · External reference
Right ventricular dysfunction following surgical repair of tetralogy of fallot: molecular pathways and therapeutic prospects
10.1016/j.biopha.2025.117924 · 2025 · External reference
Sirt3 activates autophagy to prevent DOX-Induced senescence by inactivating PI3K/AKT/mTOR pathway in A549 cells
10.1016/j.bbamcr.2022.119411 · 2023 · External reference
Exploiting the dynamics of the EPR effect and strategies to improve the therapeutic effects of nanomedicines by using EPR effect enhancers
10.1016/j.addr.2020.06.005 · 2020 · External reference
Preclinical development of a miR-132 inhibitor for heart failure treatment
10.1038/s41467-020-14349-2 · 2020 · External reference
Navigating the landscape of RNA delivery systems in cardiovascular disease therapeutics
10.1016/j.addr.2024.115302 · 2024 · External reference
NF-kappaB activation by reactive oxygen species: fifteen years later
10.1016/j.bcp.2006.04.011 · 2006 · External reference
Irigenin treatment alleviates doxorubicin (DOX)-induced cardiotoxicity by suppressing apoptosis, inflammation and oxidative stress via the increase of miR-425
10.1016/j.biopha.2019.109784 · 2020 · External reference
microRNA-377 signaling modulates anticancer drug-induced cardiotoxicity in mice
10.3389/fcvm.2021.737826 · 2021 · External reference
Dapagliflozin mitigates doxorubicin-caused myocardium damage by regulating AKT-mediated oxidative stress, cardiac remodeling, and inflammation
10.3390/ijms231710146 · 2022 · External reference
miR-200a attenuated doxorubicin-induced cardiotoxicity through upregulation of Nrf2 in mice
10.1155/2019/1512326 · 2019 · External reference
Systematic analysis of doxorubicin-induced myocardial injury mechanisms using network toxicology and molecular docking strategy
2025 · External reference
MicroRNA-29b regulates the mitochondria-dependent apoptotic pathway by targeting bax in doxorubicin cardiotoxicity
10.1159/000491896 · 2018 · External reference
Autophagy and mitophagy in the context of doxorubicin-induced cardiotoxicity
10.18632/oncotarget.16944 · 2017 · External reference
Underlying the mechanisms of doxorubicin-induced acute cardiotoxicity: oxidative stress and cell death
10.7150/ijbs.65258 · 2022 · External reference
MicroRNA in the diagnosis and treatment of doxorubicin-induced cardiotoxicity
10.3390/biom13030568 · 2023 · External reference
Incidence, risk factors and early prediction of doxorubicin-induced cardiotoxicity by global longitudinal strain and cardiac biomarkers in Indian patients with lymphoma: a prospective observational study
10.1016/j.clml.2024.10.008 · 2025 · External reference
Mitochondrial metabolism in aging heart
10.1161/circresaha.116.307505 · 2016 · External reference
Mechanism of action of non-coding RNAs and traditional Chinese medicine in myocardial fibrosis: focus on the TGF-beta/Smad signaling pathway
2023 · External reference
miR-451 silencing inhibited doxorubicin exposure-induced cardiotoxicity in mice
2019 · External reference
Exploring the role of ferroptosis in the doxorubicin-induced chronic cardiotoxicity using a murine model
10.1016/j.cbi.2022.110008 · 2022 · External reference
Inhibition of miR-25 attenuates doxorubicin-induced apoptosis, reactive oxygen species production and DNA damage by targeting PTEN
10.7150/ijms.41980 · 2020 · External reference
MicroRNA-133b alleviates doxorubicin-induced cardiomyocyte apoptosis and cardiac fibrosis by targeting PTBP1 and TAGLN2
10.3892/ijmm.2021.4958 · 2021 · External reference
Rutaecarpine inhibits doxorubicin-induced oxidative stress and apoptosis by activating AKT signaling pathway
2021 · External reference
Taxifolin protects against doxorubicin-induced cardiotoxicity and ferroptosis by adjusting microRNA-200a-mediated Nrf2 signaling pathway
10.1016/j.heliyon.2023.e22011 · 2023 · External reference
A review of the pathophysiological mechanisms of doxorubicin-induced cardiotoxicity and aging
10.1038/s41514-024-00135-7 · 2024 · External reference
MiR-124 attenuates doxorubicin-induced cardiac injury via inhibiting p66Shc-mediated oxidative stress
10.1016/j.bbrc.2019.10.157 · 2020 · External reference
MicroRNA-495-3p diminishes doxorubicin-induced cardiotoxicity through activating AKT
10.1111/jcmm.17230 · 2022 · External reference
Doxorubicin induces cardiomyocyte pyroptosis via the TINCR-mediated posttranscriptional stabilization of NLR family pyrin domain containing 3
10.1016/j.yjmcc.2019.08.009 · 2019 · External reference
Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity
10.1124/pr.56.2.6 · 2004 · External reference
Molecular mechanisms of cardiotoxicity: a review on major side-effect of doxorubicin
2017 · External reference
Sexual dimorphism of doxorubicin-mediated cardiotoxicity: potential role of energy metabolism remodeling
10.1161/circheartfailure.114.001180 · 2015 · External reference
Autosis A new target to prevent cell death
10.1016/j.jacbts.2020.04.014 · 2020 · External reference
miR-146a attenuates apoptosis and modulates autophagy by targeting TAF9b/P53 pathway in doxorubicin-induced cardiotoxicity
10.1038/s41419-019-1901-x · 2019 · External reference
Doxorubicin-induced modulation of TGF-beta signaling cascade in mouse fibroblasts: insights into cardiotoxicity mechanisms
10.1038/s41598-023-46216-7 · 2023 · External reference
The role of MicroRNAs in the pathogenesis of doxorubicin-induced vascular remodeling
10.3390/ijms252413335 · 2024 · External reference
TGF-beta/Smad3 signaling promotes renal fibrosis by inhibiting miR-29
10.1681/asn.2010121308 · 2011 · External reference
Doxorubicin-induced cardiotoxicity: an update on the molecular mechanism and novel therapeutic strategies for effective management
10.1016/j.biopha.2021.111708 · 2021 · External reference
Advanced maturation of human cardiac tissue grown from pluripotent stem cells
10.1038/s41586-018-0016-3 · 2018 · External reference
Role of microRNAs in doxorubicin-induced cardiotoxicity: an overview of preclinical models and cancer patients
10.1007/s10741-017-9653-0 · 2018 · External reference
An overview of microRNAs: biology, functions, therapeutics, and analysis methods
10.1002/jcp.27486 · 2019 · External reference
Cardiac dysfunction in the trastuzumab clinical trials experience
10.1200/jco.2002.20.5.1215 · 2002 · External reference
Novel role of T cells and IL-6 (Interleukin-6) in angiotensin II-Induced microvascular dysfunction
10.1161/hypertensionaha.118.12286 · 2019 · External reference
microRNAs in action: biogenesis, function and regulation
10.1038/s41576-023-00611-y · 2023 · External reference
Role of oxidative stress and inflammation-related signaling pathways in doxorubicin-induced cardiomyopathy
10.1186/s12964-023-01077-5 · 2023 · External reference
Anthracycline-induced cardiotoxicity: overview of studies examining the roles of oxidative stress and free cellular iron
10.1016/s1734-1140(09)70018-0 · 2009 · External reference
MicroRNAs in the diagnosis and prevention of drug-induced cardiotoxicity
10.1007/s00204-018-2356-z · 2019 · External reference
Mechanisms of doxorubicin-induced cardiac inflammation and fibrosis; therapeutic targets and approaches
10.1016/j.abb.2024.110140 · 2024 · External reference
Sex differences in doxorubicin-induced cardiotoxicity: insights from transcriptome analysis
2024 · External reference
Doxorubicin-induced cardiac remodeling: mechanisms and mitigation strategies
2025 · External reference
Mitochondrial outer membrane protein FUNDC2 promotes ferroptosis and contributes to doxorubicin-induced cardiomyopathy
10.1073/pnas.2117396119 · 2022 · External reference
MiRNAs: biology, biogenesis, their web-based tools, and databases
10.2174/2211536607666180827111633 · 2019 · External reference
Doxorubicin-induced cardiomyocyte apoptosis: role of mitofusin 2
10.1016/j.biocel.2017.05.006 · 2017 · External reference
Defined engineered human myocardium with advanced maturation for applications in heart failure modeling and repair
10.1161/circulationaha.116.024145 · 2017 · External reference
MiR-21 protected cardiomyocytes against doxorubicin-induced apoptosis by targeting BTG2
10.3390/ijms160714511 · 2015 · External reference
RNAi-Based therapeutics and novel RNA bioengineering technologies
10.1124/jpet.122.001234 · 2023 · External reference
Use of microRNAs as diagnostic, prognostic, and therapeutic tools for glioblastoma
10.3390/ijms25052464 · 2024 · External reference
New insights into the activities and toxicities of the old anticancer drug doxorubicin
10.1111/febs.15583 · 2021 · External reference
Catalytic inhibitors of topoisomerase II differently modulate the toxicity of anthracyclines in cardiac and cancer cells
10.1371/journal.pone.0076676 · 2013 · External reference
Molecular mechanisms of doxorubicin-induced cardiotoxicity: novel roles of sirtuin 1-mediated signaling pathways
10.1007/s00018-020-03729-y · 2021 · External reference
miR-21-5p prevents doxorubicin-induced cardiomyopathy by downregulating BTG2
2023 · External reference
Protective effect of miR378* on doxorubicin-induced cardiomyocyte injury via calumenin
10.1002/jcp.26615 · 2018 · External reference
The role of microRNA in the development, diagnosis, and treatment of cardiovascular disease: recent developments
10.1124/jpet.121.001152 · 2023 · External reference
Molecular insights into oxidative-stress-mediated cardiomyopathy and potential therapeutic strategies
10.3390/biom15050670 · 2025 · External reference
Effects by doxorubicin on the myocardium are mediated by oxygen free radicals
10.1016/s0024-3205(00)00990-5 · 2001 · External reference
miR-488-3p protects cardiomyocytes against doxorubicin-induced cardiotoxicity by inhibiting CyclinG1
2022 · External reference
Doxorubicin, DNA torsion, and chromatin dynamics
2014 · External reference
Dexrazoxane protects cardiomyocyte from doxorubicin-induced apoptosis by modulating miR-17-5p
2020 · External reference
Reduction of elevated proton leak rejuvenates mitochondria in the aged cardiomyocyte
10.7554/elife.60827 · 2020 · External reference
Activation of Nrf2 by miR-152 inhibits doxorubicin-induced cardiotoxicity via attenuation of oxidative stress, inflammation, and apoptosis
2021 · External reference
Inhibition of miR-128-3p attenuated doxorubicin-triggered acute cardiac injury in mice by the regulation of PPAR-gamma
10.1155/2021/7595374 · 2021 · External reference
MicroRNA-140-5p aggravates doxorubicin-induced cardiotoxicity by promoting myocardial oxidative stress via targeting Nrf2 and Sirt2
10.1016/j.redox.2017.12.013 · 2018 · External reference
Protective effect of dioscin against doxorubicin-induced cardiotoxicity via adjusting microRNA-140-5p-mediated myocardial oxidative stress
10.1016/j.redox.2018.02.026 · 2018 · External reference
Corrigendum to 'Protective effect of dioscin against doxorubicin-induced cardiotoxicity via adjusting microRNA-140-5p-mediated myocardial oxidative stress' [Redox Biol.], 2018, 16: 189-198
10.1016/j.redox.2019.101303 · 2019 · External reference
MiR-24-3p modulates cardiac function in doxorubicin -induced heart failure via the Sp1/PI3K signaling pathway
10.1016/j.cellsig.2024.111407 · 2024 · External reference
Smad3-mediated upregulation of miR-21 promotes renal fibrosis
10.1681/asn.2010111168 · 2011 · External reference
Inhibiting mir-34a-5p regulates doxorubicin-induced autophagy disorder and alleviates myocardial pyroptosis by targeting Sirt3-AMPK pathway
10.1016/j.biopha.2023.115654 · 2023 · External reference
Protective effect of miR378* on doxorubicin-induced cardiomyocyte injury via calumenin
10.1002/jcp.26615 · ExternalCitation · doi-reference
An overview of microRNAs: biology, functions, therapeutics, and analysis methods
10.1002/jcp.27486 · ExternalCitation · doi-reference
Molecular mechanisms of doxorubicin-induced cardiotoxicity: novel roles of sirtuin 1-mediated signaling pathways
10.1007/s00018-020-03729-y · ExternalCitation · doi-reference
MicroRNAs in the diagnosis and prevention of drug-induced cardiotoxicity
10.1007/s00204-018-2356-z · ExternalCitation · doi-reference
Role of microRNAs in doxorubicin-induced cardiotoxicity: an overview of preclinical models and cancer patients
10.1007/s10741-017-9653-0 · ExternalCitation · doi-reference
Protocol for a retrospective, controlled cohort study of the impact of a change in nature journals' editorial policy for life sciences research on the completeness of reporting study design and execution
10.1007/s11192-016-1964-8 · ExternalCitation · doi-reference
Mechanisms of doxorubicin-induced cardiac inflammation and fibrosis; therapeutic targets and approaches
10.1016/j.abb.2024.110140 · ExternalCitation · doi-reference
Exploiting the dynamics of the EPR effect and strategies to improve the therapeutic effects of nanomedicines by using EPR effect enhancers
10.1016/j.addr.2020.06.005 · ExternalCitation · doi-reference
Navigating the landscape of RNA delivery systems in cardiovascular disease therapeutics
10.1016/j.addr.2024.115302 · ExternalCitation · doi-reference
Sirt3 activates autophagy to prevent DOX-Induced senescence by inactivating PI3K/AKT/mTOR pathway in A549 cells
10.1016/j.bbamcr.2022.119411 · ExternalCitation · doi-reference
MiR-124 attenuates doxorubicin-induced cardiac injury via inhibiting p66Shc-mediated oxidative stress
10.1016/j.bbrc.2019.10.157 · ExternalCitation · doi-reference
NF-kappaB activation by reactive oxygen species: fifteen years later
10.1016/j.bcp.2006.04.011 · ExternalCitation · doi-reference
Doxorubicin-induced cardiomyocyte apoptosis: role of mitofusin 2
10.1016/j.biocel.2017.05.006 · ExternalCitation · doi-reference
Irigenin treatment alleviates doxorubicin (DOX)-induced cardiotoxicity by suppressing apoptosis, inflammation and oxidative stress via the increase of miR-425
10.1016/j.biopha.2019.109784 · ExternalCitation · doi-reference
Doxorubicin-induced cardiotoxicity: an update on the molecular mechanism and novel therapeutic strategies for effective management
10.1016/j.biopha.2021.111708 · ExternalCitation · doi-reference
Inhibiting mir-34a-5p regulates doxorubicin-induced autophagy disorder and alleviates myocardial pyroptosis by targeting Sirt3-AMPK pathway
10.1016/j.biopha.2023.115654 · ExternalCitation · doi-reference
Right ventricular dysfunction following surgical repair of tetralogy of fallot: molecular pathways and therapeutic prospects
10.1016/j.biopha.2025.117924 · ExternalCitation · doi-reference
Exploring the role of ferroptosis in the doxorubicin-induced chronic cardiotoxicity using a murine model
10.1016/j.cbi.2022.110008 · ExternalCitation · doi-reference
MiR-24-3p modulates cardiac function in doxorubicin -induced heart failure via the Sp1/PI3K signaling pathway
10.1016/j.cellsig.2024.111407 · ExternalCitation · doi-reference
Incidence, risk factors and early prediction of doxorubicin-induced cardiotoxicity by global longitudinal strain and cardiac biomarkers in Indian patients with lymphoma: a prospective observational study
10.1016/j.clml.2024.10.008 · ExternalCitation · doi-reference
Taxifolin protects against doxorubicin-induced cardiotoxicity and ferroptosis by adjusting microRNA-200a-mediated Nrf2 signaling pathway
10.1016/j.heliyon.2023.e22011 · ExternalCitation · doi-reference
Intercalation of antitumor drug doxorubicin and its analogue by DNA duplex: structural features and biological implications
10.1016/j.ijbiomac.2014.02.028 · ExternalCitation · doi-reference
Autosis A new target to prevent cell death
10.1016/j.jacbts.2020.04.014 · ExternalCitation · doi-reference
Anthracycline cardiotoxicity in adult cancer patients: JACC: cardiooncology State-of-the-Art review
10.1016/j.jaccao.2024.07.016 · ExternalCitation · doi-reference
Metformin ameliorates doxorubicin-induced cardiotoxicity targeting HMGB1/TLR4/NLRP3 signaling pathway in mice
10.1016/j.lfs.2023.121390 · ExternalCitation · doi-reference
MicroRNA-140-5p aggravates doxorubicin-induced cardiotoxicity by promoting myocardial oxidative stress via targeting Nrf2 and Sirt2
10.1016/j.redox.2017.12.013 · ExternalCitation · doi-reference
Protective effect of dioscin against doxorubicin-induced cardiotoxicity via adjusting microRNA-140-5p-mediated myocardial oxidative stress
10.1016/j.redox.2018.02.026 · ExternalCitation · doi-reference
Corrigendum to 'Protective effect of dioscin against doxorubicin-induced cardiotoxicity via adjusting microRNA-140-5p-mediated myocardial oxidative stress' [Redox Biol.], 2018, 16: 189-198
10.1016/j.redox.2019.101303 · ExternalCitation · doi-reference
Doxorubicin induces cardiomyocyte pyroptosis via the TINCR-mediated posttranscriptional stabilization of NLR family pyrin domain containing 3
10.1016/j.yjmcc.2019.08.009 · ExternalCitation · doi-reference
Effects by doxorubicin on the myocardium are mediated by oxygen free radicals
10.1016/s0024-3205(00)00990-5 · ExternalCitation · doi-reference
Anthracycline-induced cardiotoxicity: overview of studies examining the roles of oxidative stress and free cellular iron
10.1016/s1734-1140(09)70018-0 · ExternalCitation · doi-reference
miR-146a attenuates apoptosis and modulates autophagy by targeting TAF9b/P53 pathway in doxorubicin-induced cardiotoxicity
10.1038/s41419-019-1901-x · ExternalCitation · doi-reference
Preclinical development of a miR-132 inhibitor for heart failure treatment
10.1038/s41467-020-14349-2 · ExternalCitation · doi-reference
A review of the pathophysiological mechanisms of doxorubicin-induced cardiotoxicity and aging
10.1038/s41514-024-00135-7 · ExternalCitation · doi-reference
microRNAs in action: biogenesis, function and regulation
10.1038/s41576-023-00611-y · ExternalCitation · doi-reference
Advanced maturation of human cardiac tissue grown from pluripotent stem cells
10.1038/s41586-018-0016-3 · ExternalCitation · doi-reference
Doxorubicin-induced modulation of TGF-beta signaling cascade in mouse fibroblasts: insights into cardiotoxicity mechanisms
10.1038/s41598-023-46216-7 · ExternalCitation · doi-reference
Bnip3 mediates doxorubicin-induced cardiac myocyte necrosis and mortality through changes in mitochondrial signaling
10.1073/pnas.1414665111 · ExternalCitation · doi-reference
Mitochondrial outer membrane protein FUNDC2 promotes ferroptosis and contributes to doxorubicin-induced cardiomyopathy
10.1073/pnas.2117396119 · ExternalCitation · doi-reference
New insights into the activities and toxicities of the old anticancer drug doxorubicin
10.1111/febs.15583 · ExternalCitation · doi-reference
MicroRNA-495-3p diminishes doxorubicin-induced cardiotoxicity through activating AKT
10.1111/jcmm.17230 · ExternalCitation · doi-reference
The role of microRNA in the development, diagnosis, and treatment of cardiovascular disease: recent developments
10.1124/jpet.121.001152 · ExternalCitation · doi-reference
RNAi-Based therapeutics and novel RNA bioengineering technologies
10.1124/jpet.122.001234 · ExternalCitation · doi-reference
Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity
10.1124/pr.56.2.6 · ExternalCitation · doi-reference
Cardiac fibroblasts: friend or foe?
10.1152/ajpheart.00023.2006 · ExternalCitation · doi-reference
Oxidative stress and cellular response to doxorubicin: a common factor in the complex milieu of anthracycline cardiotoxicity
10.1155/2017/1521020 · ExternalCitation · doi-reference
miR-200a attenuated doxorubicin-induced cardiotoxicity through upregulation of Nrf2 in mice
10.1155/2019/1512326 · ExternalCitation · doi-reference
Protective effect of miR-204 on doxorubicin-induced cardiomyocyte injury via HMGB1
10.1155/2020/8819771 · ExternalCitation · doi-reference
Inhibition of miR-128-3p attenuated doxorubicin-triggered acute cardiac injury in mice by the regulation of PPAR-gamma
10.1155/2021/7595374 · ExternalCitation · doi-reference
MicroRNA-29b regulates the mitochondria-dependent apoptotic pathway by targeting bax in doxorubicin cardiotoxicity
10.1159/000491896 · ExternalCitation · doi-reference
Sexual dimorphism of doxorubicin-mediated cardiotoxicity: potential role of energy metabolism remodeling
10.1161/circheartfailure.114.001180 · ExternalCitation · doi-reference
Mitochondrial metabolism in aging heart
10.1161/circresaha.116.307505 · ExternalCitation · doi-reference
Defined engineered human myocardium with advanced maturation for applications in heart failure modeling and repair
10.1161/circulationaha.116.024145 · ExternalCitation · doi-reference
Novel role of T cells and IL-6 (Interleukin-6) in angiotensin II-Induced microvascular dysfunction
10.1161/hypertensionaha.118.12286 · ExternalCitation · doi-reference
Role of oxidative stress and inflammation-related signaling pathways in doxorubicin-induced cardiomyopathy
10.1186/s12964-023-01077-5 · ExternalCitation · doi-reference
Cardiac dysfunction in the trastuzumab clinical trials experience
10.1200/jco.2002.20.5.1215 · ExternalCitation · doi-reference
Catalytic inhibitors of topoisomerase II differently modulate the toxicity of anthracyclines in cardiac and cancer cells
10.1371/journal.pone.0076676 · ExternalCitation · doi-reference
Smad3-mediated upregulation of miR-21 promotes renal fibrosis
10.1681/asn.2010111168 · ExternalCitation · doi-reference
TGF-beta/Smad3 signaling promotes renal fibrosis by inhibiting miR-29
10.1681/asn.2010121308 · ExternalCitation · doi-reference
Autophagy and mitophagy in the context of doxorubicin-induced cardiotoxicity
10.18632/oncotarget.16944 · ExternalCitation · doi-reference
Doxorubicin-induced loss of DNA topoisomerase II and DNMT1- dependent suppression of MiR-125b induces chemoresistance in ALK-positive cells
10.18632/oncotarget.24465 · ExternalCitation · doi-reference
MiRNAs: biology, biogenesis, their web-based tools, and databases
10.2174/2211536607666180827111633 · ExternalCitation · doi-reference
microRNA-377 signaling modulates anticancer drug-induced cardiotoxicity in mice
10.3389/fcvm.2021.737826 · ExternalCitation · doi-reference
MicroRNA-194-5p attenuates doxorubicin-induced cardiomyocyte apoptosis and endoplasmic reticulum stress by targeting P21-Activated kinase 2
10.3389/fcvm.2022.815916 · ExternalCitation · doi-reference
MicroRNA in the diagnosis and treatment of doxorubicin-induced cardiotoxicity
10.3390/biom13030568 · ExternalCitation · doi-reference
Molecular insights into oxidative-stress-mediated cardiomyopathy and potential therapeutic strategies
10.3390/biom15050670 · ExternalCitation · doi-reference
A comprehensive review on collagen type I development of biomaterials for tissue engineering: from biosynthesis to bioscaffold
10.3390/biomedicines10092307 · ExternalCitation · doi-reference
The role of miRNAs in chemotherapy-induced cardiotoxicity
10.3390/biomedicines13102331 · ExternalCitation · doi-reference
MiR-21 protected cardiomyocytes against doxorubicin-induced apoptosis by targeting BTG2
10.3390/ijms160714511 · ExternalCitation · doi-reference
Dapagliflozin mitigates doxorubicin-caused myocardium damage by regulating AKT-mediated oxidative stress, cardiac remodeling, and inflammation
10.3390/ijms231710146 · ExternalCitation · doi-reference
Use of microRNAs as diagnostic, prognostic, and therapeutic tools for glioblastoma
10.3390/ijms25052464 · ExternalCitation · doi-reference
miRNA expression profiles in isolated ventricular cardiomyocytes: insights into doxorubicin-induced cardiotoxicity
10.3390/ijms25105272 · ExternalCitation · doi-reference
The role of MicroRNAs in the pathogenesis of doxorubicin-induced vascular remodeling
10.3390/ijms252413335 · ExternalCitation · doi-reference
Pathophysiology of doxorubicin-mediated cardiotoxicity
10.3390/toxics13040277 · ExternalCitation · doi-reference
MicroRNA-133b alleviates doxorubicin-induced cardiomyocyte apoptosis and cardiac fibrosis by targeting PTBP1 and TAGLN2
10.3892/ijmm.2021.4958 · ExternalCitation · doi-reference
Underlying the mechanisms of doxorubicin-induced acute cardiotoxicity: oxidative stress and cell death
10.7150/ijbs.65258 · ExternalCitation · doi-reference
Inhibition of miR-25 attenuates doxorubicin-induced apoptosis, reactive oxygen species production and DNA damage by targeting PTEN
10.7150/ijms.41980 · ExternalCitation · doi-reference
Reduction of elevated proton leak rejuvenates mitochondria in the aged cardiomyocyte
10.7554/elife.60827 · ExternalCitation · doi-reference
